ashland.com (ASH): Price-to-Projected Revenue Ratio
Ashland Inc. is pursuing a strategic course focused on restructuring and profit growth within the niche pharmaceutical chemistry segment. The forward P/S ratio demonstrates the progress of this transformation, with 0.00 serving as the current metric level. Unique formulations and patent purity provide a defensive moat for the business. Stringent FDA regulations create a high barrier to entry, as switching component suppliers would result in the loss of licensure.
Analytical breakdowns for Ashland Inc.
- current price and projected stock value:
- stock exchange capitalization data:
- book value of equity indicators:
- company total debt and liquidity indicators:
- financial results and valuation multiples details:
ASH - Net Profit|Expected Profit Ashland Inc.|ASH - Business Payback Period|Forward P/E Multiple Ashland Global|ASH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Ashland Corp|ASH - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Ashland|ASH - Earnings per share for the trailing year|Quarterly EPS earnings growth ashland.com|ASH - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Ashland Inc.
- sales and revenue indicators:
Fundamental company valuation:Ashland ASH
The forward P/S ratio reflects market capitalization relative to projected revenue, capturing the dynamics of investor expectations in real time. Analyzing the forward P/S valuation allows for the identification of asset overheating or the undervaluation of Ashland Inc. (ASH), given the sensitivity of chemical production to raw material volatility and cyclical demand within the pharmaceutical sector.
Competitors of Ashland Inc. (ASH)
Forward P/S Multiple LIN (Linde)|Forward P/S Multiple Air Products & Chemicals, Inc. APD|DD - Price-to-Projected Revenue Ratio|IP (IP Corp) - Market Cap to Projected Revenue|PPG: Forward P/S Multiple|Market Cap to Projected Revenue DOW|Forward Price-to-Revenue Multiple LYB|IFF: Forward Price to Sales|Forward P/S Multiple RPM|Market Cap to Expected Sales Ratio Entegris Corporation|Price-to-Projected Revenue Ratio Suzano S.A. SUZ|WLK: Market Cap to Projected Revenue|Albemarle Corporation - Forward P/S Multiple|Israel Chemicals (ICL) - Forward Price-to-Revenue Multiple|NEU (Afton Chemical) - Forward Price-to-Revenue Multiple|EMN - Market Cap to Expected Sales Ratio|AXTA (Axalta Coating Systems) - Forward P/S Multiple|Forward P/S Multiple elementsolutionsinc.com|Price-to-Projected Revenue Ratio Sociedad Química y Minera de Chile (SQM)|Market Cap to Expected Sales Ratio Celanese Corp|Forward P/S Multiple SXT (Sensient Corp)|Forward Price to Sales CBT|Hawkins, Inc. - Forward P/S Multiple|avient.com (AVNT) - Forward Price-to-Revenue Multiple|FUL: Forward P/S Multiple|Methanex Corp - Forward Price to Sales|WDFC (WD-40 Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Chemours Co. CC|Price-to-Projected Revenue Ratio Quaker Chemical (KWR)|Forward Price-to-Revenue Multiple purecycletech.com PCT|Forward P/S Multiple NGVT (Ingevity)|Market Cap to Expected Sales Ratio Innospec Inc (IOSP)|MTX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Daqo Solar DQ|SLVM (Sylvamo Corporation) - Forward Price-to-Revenue Multiple|HUN: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio Albany International Corp.|CLMT: Forward Price to Sales|Forward Price-to-Revenue Multiple ROG (Rogers Advanced Electronics)|SCL - Market Cap to Future Revenue Ratio|Forward P/S Multiple ECVT (Ecovyst Inc.)|Forward P/S Multiple neogenomics.com NEO|REX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio ASP Isotopes Inc ASPI|TROX: Forward P/S Multiple|Ferroglobe Group - Forward Price to Sales|Price-to-Projected Revenue Ratio Westlake Chemical Partners|Price-to-Projected Revenue Ratio CMP|Forward P/S Multiple KRO|Forward P/S Multiple Mativ Holdings Inc (MATV)|Price-to-Projected Revenue Ratio LSB Corp LXU|BAK: Market Cap to Projected Revenue|Koppers Holdings Inc. - Forward P/S Multiple|ASIX (advansix.com) - Market Cap to Projected Revenue|OEC (Orion) - Forward Price-to-Revenue Multiple|Rayonier Advanced Materials Inc. - Forward Price to Sales|ADUR (Aduro Corp) - Forward P/S Multiple|Magnera Group (MAGN) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Clearwater Paper (CLW)|tredegar.com - Market Cap to Projected Revenue|Forward P/S Multiple CMT (Core Molding Technologies, Inc.)|FF - Forward Price-to-Revenue Multiple|FSI: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Alto Ingredients, Inc. ALTO|FEAM: Forward P/S Multiple|Trinseo (TSE) - Forward P/S Multiple|Price-to-Projected Revenue Ratio Origin Materials Inc|Northern Technologies International Corporation (NTIC) - Market Cap to Expected Sales Ratio|Forward P/S Multiple LNZA|YMAT (ymaunivers.com) - Forward Price to Sales|Forward P/S Multiple NUAI (New Era Helium)|BSLK - Forward Price-to-Revenue Multiple|BioNexus Gene Lab Corporation - Forward P/S Multiple|Forward Price to Sales GURE (Gulf Resources Inc.)|CNEY: Forward P/S Multiple|Market Cap to Future Revenue Ratio Arcadium Lithium (ALTM)|Price-to-Projected Revenue Ratio Danimer Scientific|Forward Price-to-Revenue Multiple Glatfelter Corp. (GLT)|Forward P/S Multiple GRFX|Market Cap to Expected Sales Ratio U.S. Silica Holdings, Inc.|Price-to-Projected Revenue Ratio Invizyne IZTC
